Anelli Viviana, Ordas Anita, Kneitz Susanne, Sagredo Leonel Munoz, Gourain Victor, Schartl Manfred, Meijer Annemarie H, Mione Marina
Cibio, University of Trento, Trento, Italy.
Institute of Biology, Leiden University, Leiden, Netherlands.
Front Genet. 2018 Dec 18;9:675. doi: 10.3389/fgene.2018.00675. eCollection 2018.
Ras genes are among the most commonly mutated genes in human cancer; yet our understanding of their oncogenic activity at the molecular mechanistic level is incomplete. To identify downstream events that mediate ras-induced cellular transformation , we analyzed global microRNA expression in three different models of Ras-induction and tumor formation in zebrafish. Six microRNAs were found increased in Ras-induced melanoma, glioma and in an inducible model of ubiquitous Ras expression. The upregulation of the microRNAs depended on the activation of the ERK and AKT pathways and to a lesser extent, on mTOR signaling. Two Ras-induced microRNAs (miR-146a and 193a) target Jmjd6, inducing downregulation of its mRNA and protein levels at the onset of Ras expression during melanoma development. However, at later stages of melanoma progression, levels were found elevated. The dynamic of Jmjd6 levels during progression of melanoma in the zebrafish model suggests that upregulation of the microRNAs targeting Jmjd6 may be part of an anti-cancer response. Indeed, triple transgenic fish engineered to express a microRNA-resistant Jmjd6 from the onset of melanoma have increased tumor burden, higher infiltration of leukocytes and shorter melanoma-free survival. Increased expression is found in several human cancers, including melanoma, suggesting that the up-regulation of Jmjd6 is a critical event in tumor progression. The following link has been created to allow review of record GSE37015: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=jjcrbiuicyyqgpc&acc=GSE37015.
Ras基因是人类癌症中最常发生突变的基因之一;然而,我们在分子机制层面上对其致癌活性的理解并不完整。为了确定介导Ras诱导的细胞转化的下游事件,我们分析了斑马鱼中三种不同的Ras诱导和肿瘤形成模型中的全局微小RNA表达。在Ras诱导的黑色素瘤、神经胶质瘤以及无处不在的Ras表达的可诱导模型中,发现有六种微小RNA增加。这些微小RNA的上调依赖于ERK和AKT途径的激活,在较小程度上还依赖于mTOR信号传导。两种Ras诱导的微小RNA(miR-146a和193a)靶向Jmjd6,在黑色素瘤发展过程中Ras表达开始时诱导其mRNA和蛋白质水平下调。然而,在黑色素瘤进展的后期阶段,发现其水平升高。斑马鱼模型中黑色素瘤进展过程中Jmjd6水平的动态变化表明,靶向Jmjd6的微小RNA上调可能是抗癌反应的一部分。事实上,从黑色素瘤开始就被设计用来表达抗微小RNA的Jmjd6的三重转基因鱼具有更高的肿瘤负荷、更高的白细胞浸润以及更短的无黑色素瘤生存期。在包括黑色素瘤在内的几种人类癌症中发现Jmjd6表达增加,这表明Jmjd6的上调是肿瘤进展中的一个关键事件。已创建以下链接以允许查看记录GSE